A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

Jefferies investment banker Chris Roop discussed the Big Pharma M&A outlook with Business Insider. Check out the types of ...

Although bipartisan legislation to provide Medicare coverage for obesity treatments has circulated in Congress for more than ...

The US Food and Drug Administration has approved the first ever prescribed medicine for Obstructive Sleep Apnea. Read on to ...

Weight loss drugs have risen in popularity in the recent years, but a disconnect remains between those who need the drugs and ...

Lory Osborn says the Wegovy she was prescribed 15 months ago did more than help her lose 75 pounds — over a quarter of her ...

Racial and ethnic disparities are seen in the use of obesity-management medications, according to a study published o ...

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

The 38-year-old information technology worker from New Mexico had a prescription ... Now that millions of people have used the drugs, several obesity experts told The Associated Press that ...

Dr. Bisher Mustafa of the Marshall Health Obesity Clinic in Huntington said there's a certain irony to waiting "until people have diabetes to start the medication." "The idea is to try to prevent ...